Home   Contact Palatin   Site Map  
 

Press Releases

 
2002 2003 2004 2005 all
 
 

 


Displaying releases: 1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-105 | 106-120 | 121-135 | 136-150 | 151-165 | 166-180 | 181-195 | 196-210 | 211-225 | 226-240 | 241-255 | 256-270 | 271-285 | 286-286


  Mar-06-2014 Palatin Technologies to present at the 26th Annual ROTH Conference
  Feb-24-2014 Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy of Bremelanotide in Female Hypoactive Sexual Desire Disorder
  Feb-18-2014 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on February 18, 2014
  Feb-13-2014 Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on February 18, 2014
  Jan-30-2014 Palatin Technologies to Present at the 16th Congress of the European Society for Sexual Medicine
  Jan-23-2014 Palatin Technologies, Inc. Receives $1.85 Million from Sale of New Jersey State Tax Credits
  Jan-16-2014 Palatin Technologies to Present at “TEN”, Noble Financial Capital Markets’ Tenth Annual Equity Conference
  Jan-13-2014 Palatin Technologies Responds to Unusual Market Activity
  Dec-02-2013 Palatin Technologies To Participate In The 25th Annual Piper Jaffray Healthcare Conference
  Nov-14-2013 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
  Nov-13-2013 Palatin Technologies Announces Option for License to Bremelanotide in Europe
  Nov-12-2013 Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
  Nov-11-2013 Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on November 14, 2013
  Oct-28-2013 Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
  Oct-04-2013 PALATIN TECHNOLOGIES TO PRESENT AT THE 12TH ANNUAL BIO INVESTOR FORUM